Novavax AB
Development of innovative vaccines
- B2B
- B2G
About Novavax AB
A biotechnology company focused on developing innovative vaccines for infectious diseases using recombinant nanoparticles and Matrix-M™ adjuvant technology
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Uppsala, Uppsala County, Sweden
- Revenue
- $36.9M – $291MTamtam estimate
- Website
- novavax.com
- linkedin.com/company/novavax-ab
Novavax AB at a glance
Novavax AB is a B2B/B2G company in the Pharmaceutical Manufacturing industry, headquartered in Uppsala, Uppsala County, Sweden.
Novavax AB has 51–250 employees.
Novavax AB's revenue is $36.9M – $291M (Tamtam estimate).
Frequently asked questions about Novavax AB
What is Novavax AB's revenue?
Tamtam estimates Novavax AB's annual revenue at $36.9M – $291M.
How many employees does Novavax AB have?
Novavax AB has 51–250 employees.
Where is Novavax AB headquartered?
Novavax AB is headquartered in Uppsala, Uppsala County, Sweden.
Selling to companies like Novavax AB?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies